Enzon Pharmaceuticals (ENZN) Short Interest Ratio & Short Volume $0.09 +0.00 (+0.22%) As of 05/28/2025 02:52 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock Enzon Pharmaceuticals Short Interest DataEnzon Pharmaceuticals (ENZN) has a short interest of 3,500 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 55,133 shares to cover all short positions.Current Short Interest3,500 sharesPrevious Short Interest3,500 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$288.75Short Interest Ratio0.2 Days to CoverLast Record DateMay 15, 2025Outstanding Shares74,215,000 sharesShort Percent of Float0.00%Today's Trading Volume67,145 sharesAverage Trading Volume55,133 sharesToday's Volume Vs. Average122% Short Selling Enzon Pharmaceuticals? Sign up to receive the latest short interest report for Enzon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENZN Short Interest Over TimeENZN Days to Cover Over TimeENZN Percentage of Float Shorted Over Time Enzon Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20253,500 shares $288.75 No Change0.0%0.2 $0.08 4/30/20253,500 shares $315.00 No ChangeN/A0.3 $0.09 4/15/20253,500 shares $331.10 -82.8%0.0%0.1 $0.09 3/31/202520,300 shares $2,088.87 +217.2%0.0%0.4 $0.10 3/15/20256,400 shares $646.40 -12.3%0.0%0.1 $0.10 2/28/20257,300 shares $803.00 +55.3%0.0%0 $0.11 2/15/20254,700 shares $632.62 -91.5%0.0%0.1 $0.13 1/31/202555,100 shares $8,242.96 +2,523.8%N/A0.3 $0.15 1/15/20252,100 shares $301.56 -74.1%N/A0 $0.14 12/31/20248,100 shares $1,264.41 +406.3%N/A0 $0.16 Get the Latest News and Ratings for ENZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enzon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/15/20241,600 shares $182.00 No ChangeN/A0 $0.11 11/30/20241,600 shares $128.00 No ChangeN/A0 $0.08 11/15/20241,600 shares $131.20 -40.7%N/A0.1 $0.08 10/31/20242,700 shares $243.00 +68.8%N/A0 $0.09 10/15/20241,600 shares $187.52 No ChangeN/A0.1 $0.12 9/30/20241,600 shares $224.00 -33.3%N/A0.1 $0.14 9/15/20242,400 shares $302.54 +50.0%N/A0 $0.13 8/31/20241,600 shares $232.96 No ChangeN/A0.1 $0.15 8/15/20241,600 shares $256.32 -64.4%N/A0 $0.16 7/31/20244,500 shares $675.00 -61.2%N/A0.3 $0.15 7/15/202411,600 shares $1,787.56 -37.0%N/A0.8 $0.15 6/30/202418,400 shares $3,312.00 -3.7%N/A0.7 $0.18 6/15/202419,100 shares $2,677.82 -28.5%N/A0.1 $0.14 5/31/202426,700 shares $3,471.00 +1,568.8%N/A0.2 $0.13 5/15/20241,600 shares $144.00 No ChangeN/A0 $0.09 4/30/20241,600 shares $133.52 -87.6%N/A1.5 $0.08 4/15/202412,900 shares $964.92 +239.5%N/A0.6 $0.07 3/31/20243,800 shares $359.10 +137.5%N/A0.1 $0.09 3/15/20241,600 shares $132.48 -73.3%N/A0 $0.08 2/29/20246,000 shares $393.00 +275.0%N/A0.3 $0.07 2/15/20241,600 shares $144.00 -20.0%N/A0.1 $0.09 1/15/20241,600 shares $142.08 No ChangeN/A0.1 $0.09 12/31/20231,600 shares $149.68 -42.9%N/A0 $0.09 12/15/20232,800 shares $288.40 -58.2%N/A0.1 $0.10 11/30/20236,700 shares $703.50 +318.8%N/A0.1 $0.11 11/15/20231,600 shares $224.00 No ChangeN/A0.3 $0.14 10/31/20231,600 shares $240.00 No ChangeN/A0.1 $0.15 10/15/20231,600 shares $221.12 No ChangeN/A0.1 $0.14 9/30/20231,600 shares $234.68 -76.8%N/A0.2 $0.15 9/15/20236,900 shares $938.40 -42.0%N/A0.3 $0.14Trump Exec Order 14179 is wealth “gift” to good Americans? (Ad)Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.If you missed out on a bitcoin fortune, this could be your second chance. A brief “wealth window” is 8/31/202311,900 shares $1,844.50 +643.8%N/A0.7 $0.16 8/15/20231,600 shares $240.00 -27.3%N/A0.1 $0.15 7/31/20232,200 shares $440.00 No ChangeN/A0.3 $0.20 7/15/20232,200 shares $440.00 -57.7%N/A0.2 $0.20 6/30/20235,200 shares $1,040.00 +136.4%N/A0.1 $0.20 6/15/20232,200 shares $310.20 -33.3%N/A0.1 $0.14 5/31/20233,300 shares $445.50 +106.3%N/A0.1 $0.14 5/15/20231,600 shares $251.20 No ChangeN/A0 $0.16 4/30/20231,600 shares $328.00 -33.3%N/A0.2 $0.21 4/15/20232,400 shares $494.40 -7.7%N/A0.1 $0.21 3/31/20232,600 shares $676.00 -75.5%N/A0.1 $0.26 3/15/202310,600 shares $2,647.88 +523.5%N/A0.5 $0.25 2/28/20231,700 shares $433.50 -81.1%N/A0 $0.26 2/15/20239,000 shares $2,475.00 +350.0%N/A0.7 $0.28 1/31/20232,000 shares $530.00 -85.2%N/A0.2 $0.27 1/15/202313,500 shares $3,510.00 -27.0%N/A0.2 $0.26 12/30/202218,500 shares $4,563.03 No ChangeN/A0.4 $0.25 12/15/202218,500 shares $4,838.86 +1,056.3%N/A0.5 $0.26 11/30/20221,600 shares $439.68 -92.1%N/A0.1 $0.27 11/15/202220,200 shares $5,454.00 +910.0%N/A0.3 $0.27 10/31/20222,000 shares $580.00 -73.3%N/A0 $0.29 10/15/20227,500 shares $2,100.00 -7.4%N/A0.5 $0.28 9/30/20228,100 shares $2,292.30 +268.2%N/A0.1 $0.28 9/15/20222,200 shares $679.36 -66.2%N/A0.1 $0.31 8/31/20226,500 shares $1,768.00 +140.7%N/A0 $0.27 8/15/20222,700 shares $1,077.30 -54.2%N/A0 $0.40 7/31/20225,900 shares $1,976.50 +247.1%N/A0.2 $0.34 7/15/20221,700 shares $501.50 -95.2%N/A0 $0.30 6/30/202235,200 shares $10,736.00 +2,100.0%N/A0.3 $0.31 6/15/20221,600 shares $448.00 -5.9%N/A0 $0.28 5/31/20221,700 shares $518.50 -56.4%N/A0.1 $0.31 5/15/20223,900 shares $1,150.50 -81.7%N/A0.1 $0.30 4/30/202221,300 shares $6,713.76 +191.8%N/A0.2 $0.32 4/15/20227,300 shares $2,568.14 +265.0%N/A0.1 $0.35 3/31/20222,000 shares $604.80 -35.5%N/A0.1 $0.30 3/15/20223,100 shares $931.55 +24.0%N/A0.1 $0.30 2/28/20222,500 shares $800.00 -30.6%N/A0.1 $0.32 2/15/20223,600 shares $1,311.12 +125.0%N/A0 $0.36 1/31/20221,600 shares $656.00 -81.4%N/A0 $0.41 1/15/20228,600 shares $3,053.00 +437.5%N/A0.2 $0.36 12/31/20211,600 shares $548.00 No ChangeN/A0 $0.34 12/15/20211,600 shares $528.00 -76.5%N/A0 $0.33 11/30/20216,800 shares $2,512.60 -53.7%N/A0 $0.37 11/15/202114,700 shares $5,143.53 +818.8%N/A0.1 $0.35 10/29/20211,600 shares $511.52 -40.7%N/A0 $0.32 10/15/20212,700 shares $915.30 -30.8%N/A0.1 $0.34 9/30/20213,900 shares $1,471.86 -48.7%N/A0 $0.38 9/15/20217,600 shares $2,750.44 -12.6%N/A0.1 $0.36 8/31/20218,700 shares $2,872.74 +8.8%N/A0.1 $0.33 8/13/20218,000 shares $3,280.00 -16.7%N/A0 $0.41Watch This Robotics Demo Before July 23rd (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… 7/30/20219,600 shares $5,181.12 +15.7%N/A0.1 $0.54 7/15/20218,300 shares $5,436.50 +196.4%N/A0.1 $0.66 6/30/20212,800 shares $1,848.00 -60.0%N/A0 $0.66 6/15/20217,000 shares $5,173.00 -7.9%N/A0.1 $0.74 5/28/20217,600 shares $4,405.72 +31.0%N/A0.1 $0.58 5/14/20215,800 shares $3,221.90 -34.8%N/A0.1 $0.56 4/30/20218,900 shares $5,340.00 +178.1%N/A0.1 $0.60 4/15/20213,200 shares $2,300.80 -76.8%N/A0 $0.72 3/31/202113,800 shares $10,555.62 +762.5%N/A0.1 $0.76 3/15/20211,600 shares $1,008.00 -76.5%N/A0 $0.63 2/26/20216,800 shares $4,178.87 +161.5%N/A0 $0.61 2/12/20212,600 shares $1,567.28 -94.1%N/A0 $0.60 1/29/202144,400 shares $19,536.00 +21.6%N/A0.1 $0.44 1/15/202143,700 shares $13,765.50 +241.4%N/A0.1 $0.32 12/31/202024,500 shares $6,588.05 -43.9%N/A0.1 $0.27 12/15/202043,700 shares $10,925.00 +241.4%N/A0.1 $0.25 11/30/202012,800 shares $2,329.60 -36.6%N/A0.1 $0.18 11/15/202020,200 shares $3,050.20 +5.8%N/A0.2 $0.15 10/30/202019,100 shares $2,779.05 +135.8%N/A0.2 $0.15 10/15/20208,100 shares $1,297.62 +88.4%N/A0 $0.16 9/30/20204,300 shares $796.36 -62.0%N/A0.1 $0.19 9/15/202011,300 shares $1,989.93 -29.8%N/A0.1 $0.18 8/31/202016,100 shares $3,052.56 -53.9%N/A0.1 $0.19 8/14/202034,900 shares $7,503.50 +122.3%N/A0.1 $0.22 7/31/202015,700 shares $3,140.00 -38.2%N/A0.3 $0.20 7/15/202025,400 shares $4,140.20 +103.2%N/A0.8 $0.16 6/30/202012,500 shares $2,180.00 -30.2%N/A0.8 $0.17 6/15/202017,900 shares $3,141.45 -67.7%N/A0.5 $0.18 5/29/202055,400 shares $9,911.06 +32.2%N/A3 $0.18 ENZN Short Interest - Frequently Asked Questions What is Enzon Pharmaceuticals' current short interest? Short interest is the volume of Enzon Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 3,500 shares of ENZN short. 0.00% of Enzon Pharmaceuticals' shares are currently sold short. Learn More on Enzon Pharmaceuticals' current short interest. What is a good short interest percentage for Enzon Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Enzon Pharmaceuticals' floating shares are currently sold short. How does Enzon Pharmaceuticals' short interest compare to its competitors? 0.00% of Enzon Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Enzon Pharmaceuticals: Curis, Inc. (1.13%), SAB Biotherapeutics, Inc. (0.96%), Bolt Biotherapeutics, Inc. (1.02%), Molecular Templates, Inc. (5.48%), Amgen Inc. (2.68%), Gilead Sciences, Inc. (1.99%), Vertex Pharmaceuticals Incorporated (1.88%), Regeneron Pharmaceuticals, Inc. (2.69%), Alnylam Pharmaceuticals, Inc. (2.89%), Biogen Inc. (2.28%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short Enzon Pharmaceuticals stock? Short selling ENZN is an investing strategy that aims to generate trading profit from Enzon Pharmaceuticals as its price is falling. ENZN shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Enzon Pharmaceuticals? A short squeeze for Enzon Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENZN, which in turn drives the price of the stock up even further. How often is Enzon Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENZN, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies CRIS Short Squeeze SABS Short Squeeze BOLT Short Squeeze MTEM Short Squeeze AFFY Short Squeeze AMGN Short Squeeze GILD Short Squeeze VRTX Short Squeeze REGN Short Squeeze ALNY Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ENZN) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enzon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ENZN Stock Free ENZN Stock Alerts